Trade Summary

2 days ago, Ra Capital Management, L.P., serving as 10% owner at Hemab Therapeutics Holdings, Inc. (COAG), purchased 6,387 shares at $24.90 per share, for a total transaction value of $159,036.00. Following this transaction, Ra Capital Management, L.P. now holds 7,736,160 shares of COAG.

The trade was executed on Tuesday, May 12, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 14, 2026 at 5:21 PM ET, 2 days after the trade was made.

Hemab Therapeutics Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.